Skip to content

Patient experience and satisfaction and clinical results after PanOptixToric IOL implantation in both eyes of patients undergoing cataract surgery

Visual and refractive outcomes and patient satisfaction real world evaluation following bilateral implantation of AcrySof IQ PanOptixToric IOL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022808
Enrollment
33
Registered
2020-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: AcrySof IQ PanOptixToric IOL: To characterize the visual outcomes of PanOptixToric Multifocal IOL implanted to replace the natural lens in cataract patients Control Intervention1: NOT A

Sponsors

NETHRADHAMA SUPER SPECIALITY EYE HOSPITAL BANGALORE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Regular corneal topography and corneal astigmatism from 0.75 D to 4.00 D. 2. Best Corrected Visual Acuity to be 0.2 LogMAR or lower 3. Clear intraocular media 4. Availability, willingness and sufficient cognitive awareness to comply with examination procedures

Exclusion criteria

Exclusion criteria: 1. Any active ocular disease 2. Diabetic retinopathy, retinal degenerative disorders, macular degeneration, glaucoma with field defects 3. Irregular corneal astigmatism( keratoconus/ PMD) 4. Previous intraocular and corneal refractive surgery 5. Pregnancy & Lactation 6. Traumatic , Intumescent and white Cataracts 7. Subject who have retinal pathologies or dystrophies and those who are expected to require retinal laser treatment 8. Concurrent participation in another drug or device study.

Design outcomes

Primary

MeasureTime frame
Primary Endpoint: 3 Months post 2nd eye Surgery:- Corrected photopic distance visual acuity (CDVA, binocular) Timepoint: Pre-opertative/ intra-opera visits and post-operative days 1, 15, 90, 180, 365

Secondary

MeasureTime frame
1. Uncorrected and corrected photopic distance, intermediate and near visual acuity 2. Improvement in Quality of Life (Quality of Life Questionnaire developed by Rasch Analysis) 3. Refractive astigmatism 4. Spherical Equivalent 5. Binocular Defocus CurveTimepoint: 3 Months post 2nd eye surgery Post-operative visits

Countries

India

Contacts

Public ContactDR SRI GANESH

NETHRADHAMA SUPER SPECIALITY EYE HOSPITAL, BANGALORE

phacomaverick@gmail.com9854129740

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026